A New Strategy for Treating Autoimmune Disease While Maintaining Immune Function
The Chen Lab discovered a new therapeutic strategy that avoids immune deficiency while treating
autoimmune disease. Specifically, they identified immune cells that express a key immune checkpoint
receptor that drives type 1 diabetes and multiple sclerosis. The Chen Lab then created an immunotoxin that
selectively depletes these cells. Continue reading → A New Strategy for Treating Autoimmune Disease While Maintaining Immune Function